Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

Nippon Shinyaku prepares improved ciclosporin derivatives

May 9, 1997

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

May 9, 1997

Alexion issued two patents covering technology for xenotransplantation products

May 9, 1997

Zeneca and University of California to codevelop drugs for immunosuppression

May 8, 1997

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

May 7, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Novel immunosuppressants from Takeda

April 29, 1997

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

April 28, 1997

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...